Center for Radiopharmaceutical Sciences (CRS)

The PSI and ETH Zurich Center for Radiopharmaceutical Sciences covers the full range of activities for the production and clinical testing of medicinal radiocompounds.

More about us

Scientific Highlights

24.04.2024

Dr. Chiara Favaretto has been honored with the Alavi-Mandell Award 2024

We congratulate Dr. Chiara Favaretto for the excellent research work she did during her time at the Center for Radiopharmaceutical Sciences.

30.06.2023

The Executive Committee on Personalized Health and Related Technologies (PHRT) has supported the PROGNOSTIC translational Project with a Grant of CHF 2 million

The translational project "PROGNOSTICS", proposed by a consortium led by Prof. Roger Schibli, received CHF 2 million funding from the PHRT initiative of the ETH Domain(https://www.sfa-phrt.ch/two-clinical-trial-projects-launched-transforming-clinical-care-with-eth-technologies/). The study is being conducted with the Co-applicants Prof. Dr. med. Damian Wild at the University Hospital Basel and Prof. Dr. Nicola Aceto of the ETHZ. The consortium will test a new radiopharmaceutical developed at the Center for Radiopharmaceutical Sciences in 36 patients with advanced prostate cancer.

19.06.2023

ETH Rat promotes PD Dr. Cristina Müller to the rank of a Titular Professor of the ETH Zurich

Professor Dr. Cristina Müller.

19.06.2023

Prof. Roger Schibli was awarded an Honorary Fellow of the Society of Radiopharmaceutical Sciences (SRS)

Prof. Roger Schibli was awarded an Honorary Fellow of the Society of Radiopharmaceutical Sciences (SRS) “in recognition of substantial contribution to the SRS”.

More Scientific Highlights